학술논문
Long-Term Safety and Efficacy of Reslizumab in Children and Adolescents with Eosinophilic Esophagitis: A Review of 477 Doses in 12 Children over 7 Years
Document Type
Abstract
Source
In The Journal of Allergy and Clinical Immunology February 2016 137(2) Supplement:AB234-AB234
Subject
Language
ISSN
0091-6749